Q5143 Injection adalimumab-adbm, 1 milligrams
Q-Codes
Also known as: adalimumab biosimilar, Cyltezo
Injection of adalimumab-adbm (Cyltezo), a biosimilar to adalimumab, administered at 1 milligram per dose.
Clinical Context
Used for treatment of rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, and other autoimmune conditions. Adalimumab biosimilars are administered subcutaneously as maintenance therapy for TNF-mediated inflammatory diseases.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.